Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 1/20 | 0.44 |
| ▸ | HSPB1 | P04792 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 5/20 | 0.38 |
| ▸ | IDO1 | P14902 | 2/20 | 0.35 |
| ▸ | AGXT | P21549 | 2/20 | 0.35 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
| ▸ | CES1 | P23141 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28879083 | 0.83 | CA3 (0.38) | ARALDH1A1IDO1AGXTSLC22A12 | |
| SCHEMBL26420008 | 0.79 | SLC6A4 (0.43) | ALDH1A1SLC22A12 | |
| SCHEMBL19502105 | 0.79 | GAA (0.39) | ARALDH1A1 | |
| SCHEMBL98913 | 0.78 | HSPB1 (0.42) | ARHSPB1ALDH1A1TRPA1CES2 | |
| SCHEMBL22926431 | 0.78 | AR (0.48) | ARALDH1A1IDO1 | |
| SCHEMBL27532586 | 0.77 | ALDH1A1 (0.41) | ARHSPB1ALDH1A1TRPA1IDO1 | |
| SCHEMBL14703718 | 0.77 | L3MBTL1 (0.38) | ALDH1A1 | |
| SCHEMBL8961762 | 0.75 | ESR1 (0.33) | AR | |
| SCHEMBL10456772 | 0.74 | TRPA1 (0.56) | ARHSPB1ALDH1A1TRPA1 | |
| SCHEMBL2829572 | 0.71 | AR (0.42) | ARHSPB1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210022340-A1 | USE OF PYRIDINE UREA COMPOUND HAVING SNAIL-KILLING ACTIVITY | THE NATIONAL INSTITUTE OF PARASITIC DISEASES, CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION (CN) | 2021-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210022340-A1 | USE OF PYRIDINE UREA COMPOUND HAVING SNAIL-KILLING ACTIVITY | SLC14A1, UACA, UROD | AR 4809/4885HSPB1 4229/4885ALDH1A1 624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.